Summary by Moomoo AI
Mangoceuticals, Inc., a company listed on the Nasdaq Capital Market under the trading symbol MGRX, has been granted an extension by Nasdaq to regain compliance with the minimum stockholders' equity requirement. The company had previously reported stockholders' equity of $1,354,821 in its Quarterly Report for the quarter ended September 30, 2023, falling short of the Nasdaq's minimum requirement of $2,500,000. Nasdaq's notice of non-compliance was initially communicated to Mangoceuticals on November 3, 2023, and the company was given until December 18, 2023, to submit a compliance plan. Having submitted the plan on time, Mangoceuticals received notification on January 24, 2024, that Nasdaq has agreed to an extension until April 29, 2024, for the company to complete transactions that would increase its stockholders' equity above the $2.5 million threshold. The company...Show More